Providing independent clinical excellence since 2005
GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.
At Surrey Cardiovascular Clinic, we move beyond detecting risk to delivering a tiered, personalised framework for metabolic and cardiovascular prevention. Using real-time tools like CGM, the DoctorShape app, imaging, and nurse-led coaching, we help patients reduce visceral adipose tissue, improve insulin sensitivity, and restore metabolic health through lifestyle-first, data-guided care.
If you’re taking GLP-1 mimetics like Mounjaro, Ozempic, or Wegovy, you’re receiving a legitimate, medically prescribed therapy. Just like someone with asthma carries an inhaler, or a diabetic uses insulin, there’s no shame in needing a jab to support your metabolic health. Whether you are travelling or attending a hospitality event, here are some tips on how to navigate these new waters.